With reference to Regulation 52(7) Securities and Exchange Board of India (Listing Obligation and Disclosure requirements) Regulations, 2015, Genlink Pharma Solutions has informed about the disclosure under the said Regulation for the half year ended 30th September, 2019.
The above information is a part of company’s filings submitted to BSE.